Medical Health & Life Science Research News

Cystic fibrosis therapeutics market pipeline analysis made available by top research firm

Cystic fibrosis therapeutics market pipeline analysis made available by top research firm

The market for Cystic Fibrosis Therapeutics is anticipated to grow with double digit CAGR during the forecasting period. Cystic fibrosis is among the most common life-threatening genetic disorders worldwide.

- Agency -.

It is caused by defects in a single gene known as the cystic fibrosis transmembrane conductance regulator, or CFTR.

Complete report on Cystic Fibrosis Therapeutics Market available at www.marketreportsonline.com/680598.html.

- Agency -.

The increasing prevalence of cystic fibrosis, rising awareness about cystic fibrosis therapy, strong pipeline candidates, technological advancement and high rate of R&D initiatives are some of the major factors that are driving cystic fibrosis therapeutics market. However, high cost involved in treatment, increase in complexity of disease are restraining the cystic fibrosis therapeutics market.

Key Highlights of the Report

United States dominates the global market for cystic fibrosis therapeutics.

The EU5 countries together accounted for over 20% share of the global cystic fibrosis market in 2016.

In Asian region, the prevalence of Cystic Fibrosis is observed to be very low in countries like China, India and Japan.

On the basis of pharmacological class, the CFTR modulator captures highest share of the total CF therapeutics market in 2016.

In 2016, mucolyctics agents accounted for around xx% of the global cystic fibrosis therapeutics market.

Cystic Fibrosis patients who have reduced the levels of digestive enzymes due to improper functioning of pancreas, are treated by PERT to replace these enzymes.

In 20XX, TOBI Podhaler generated sales worth US$ 300 Million.

Italy has followed Ireland and other EU countries such as Germany, Austria, Denmark and Luxembourg in approving Orkambi for patients with CF.

It's estimated that 1 in every 2,500 babies born in the UK has cystic fibrosis.

The revenues for Creon increased 22 percent in 2015, driven primarily by continued market growth.

Zenpep sales surpassed US$ 200 Million mark in 2016.

Some of the drugs that are under clinical studies are Tezacaftor (VX-661) + ivacaftor, VX-445 + tezacaftor + ivacaftor, VX-659 + tezacaftor + ivacaftor, PTI-428, AZD5634, QR-010 and POL6014 among many others.

Access report: www.marketreportsonline.com/contac…e.php?name=680598.

The report titled “Cystic Fibrosis Therapeutics Market (By Major Marketed Products, Pharmacological Class, & Geography) and Pipeline Analysis – Global Forecast to 2024” provides a comprehensive assessment of the Cystic Fibrosis Therapeutics Market.

This 121 Page report with 53 Figures and 6 Tables has been studied from 8 View Points:

  1. Global Cystic Fibrosis Therapeutics Market & Forecast (2014 – 2024)
  2. Global Cystic Fibrosis Therapeutics Market - Major Marketed Products Sales & Forecast (2012 - 2024)
  3. Global Cystic Fibrosis Therapeutics Market - Pharmacological Class Sales & Forecast (2015 – 2021)
  4. By Geography - Cystic Fibrosis Therapeutics Market (2014 – 2024)
  5. Global Cystic Fibrosis Pipeline Product Analysis – By Company & Phase of Development
  6. Cystic Fibrosis Company Profiles, Approved & Pipeline Product Analysis
  7. Global Cystic Fibrosis Market - Industry Trends & Developments
  8. Global Cystic Fibrosis Market - Growth Drivers & Challenges

Global Cystic Fibrosis Therapeutics Market - Major Marketed Products Covered

  1. Orkambi (Lumacaftor/Ivacaftor)
  2. Kalydeco (Ivacaftor)
  3. Cayston (Inhaled Aztreonam)
  4. Pulmozyme (Dornase Alfa)
  5. TOBI/ TOBI Podhaler
  6. Creon
  7. Zenpep
  8. Ventolin
  9. Bronchitol (Inhaled Mannitol)
  10. ADEKplusTM
  11. Ibuprofen

Global Cystic Fibrosis Therapeutics Market - Pharmacological Class

  1. CFTR Modulators
  2. Mucolytic Agents
  3. Pancreatic Enzyme Replacement Products
  4. Antibiotics
  5. Other Therapies

Cystic Fibrosis Therapeutics Market – Geographical Analysis

  1. United States
  2. Canada
  3. France
  4. Germany
  5. Italy
  6. Spain
  7. United Kingdom
  8. Australia
  9. Japan
  10. China
  11. India
  12. South Korea

Cystic Fibrosis Company Profiles, Approved & Pipeline Product Analysis

  1. Genentech, Inc. (A Member of the Roche Group)
  2. Novartis
  3. Gilead Sciences, Inc.
  4. Vertex Pharmaceuticals Incorporated
  5. AbbVie
  6. GlaxoSmithKline
  7. Johnson & Johnson
  8. Allergan plc
  9. Pharmaxis Ltd
  10. Mylan N.V

Major Points from Table of Contents Provided in Cystic Fibrosis Therapeutics Market:

  1. Executive Summary
  2. Global Cystic Fibrosis Therapeutics Market & Forecast (2014 – 2024)
  3. Global Cystic Fibrosis Therapeutics Market Share & Forecast
    3.1 By Geography - Cystic Fibrosis Therapeutics Market Share & Forecast (2014 – 2024)
    3.2 By Pharmacological Class - Cystic Fibrosis Therapeutics Market Share & Forecast (2015 – 2021)
  4. Global Cystic Fibrosis Therapeutics Market - Major Marketed Products Sales & Forecast
    4.1 Orkambi (Lumacaftor/Ivacaftor) Sales & Forecast (2015 – 2021)
    4.2 Kalydeco (Ivacaftor) Sales & Forecast (2012 – 2021)
    4.3 Cayston (Inhaled Aztreonam) Sales & Forecast (2010 – 2021)
    4.4 Pulmozyme (Dornase Alfa) Sales & Forecast (2012 – 2021)
    4.5 TOBI/ TOBI Podhaler Sales  (2012 – 2016)
    4.6 Creon Sales & Forecast (2011 – 2021)
    4.7 Zenpep Sales & Forecast (2014 – 2021)
    4.8 Ventolin Sales & Forecast (2012 – 2021)
    4.9 Bronchitol (Inhaled Mannitol) Sales & Forecast (2013 – 2021)
    4.10 ADEKplusTM
    4.11 Ibuprofen
  5. Global Cystic Fibrosis Therapeutics Market - Pharmacological Class Sales & Forecast (2015 – 2021)
    5.1 CFTR Modulators Sales & Forecast
    5.2 Mucolytic Agents Sales & Forecast
    5.3 Pancreatic Enzyme Replacement Products Sales & Forecast
    5.4 Antibiotics Sales & Forecast
    5.5 Other Therapies Sales & Forecast
  6. By Geography - Cystic Fibrosis Therapeutics Market (2014 – 2024)
    6.1 United States Cystic Fibrosis Therapeutics Market & Forecast
    6.2 Canada Cystic Fibrosis Therapeutics Market & Forecast
    6.3 France Cystic Fibrosis Therapeutics Market & Forecast
    6.4 Germany Cystic Fibrosis Therapeutics Market & Forecast
    6.5 Italy Cystic Fibrosis Therapeutics Market & Forecast
    6.6 Spain Cystic Fibrosis Therapeutics Market & Forecast
    6.7 United Kingdom Cystic Fibrosis Therapeutics Market & Forecast
    6.8 Australia Cystic Fibrosis Therapeutics Market & Forecast
    6.9 Japan Cystic Fibrosis Therapeutics Market & Forecast
    6.10 China Cystic Fibrosis Therapeutics Market & Forecast
    6.11 India Cystic Fibrosis Therapeutics Market & Forecast
    6.12 South Korea Cystic Fibrosis Therapeutics Market & Forecast
  7. Global Cystic Fibrosis Pipeline Product Analysis – By Company & Phase of Development

News From

MarketReportsOnline - Industry Research Analysis StoreMarketReportsOnline
Category: Market Research Publishers and RetailersCompany profile: MarketReportsOnline comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.